» Articles » PMID: 7180843

Mitochondrial NADH Dehydrogenase in Cystic Fibrosis: Enzyme Kinetics in Cultured Fibroblasts

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1982 Nov 1
PMID 7180843
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Differences among cystic fibrosis (CF) genotypes (CF, obligate carriers for CF [HZ], and controls) in mitochondrial calcium pool size, oxygen (O2) consumption, and rotenone inhibition of O2 consumption led to examination of mitochondrial NADH dehydrogenase (NADH: [acceptor] oxidoreductase, E.C. 1.6.99.3). pH optima of mitochondrial NADH dehydrogenase were different in enzyme derived from whole cell homogenates of cultured skin fibroblasts of subjects with CF, HZ, and controls. We describe here apparent binding of substrate to the enzyme (Km [NADH]) in cell fractions. Km (NADH) for CF ranged from 10.9 to 16.1 micro M (no. = 7); for HZ from 20.9 to 26.3 microM (no. = 5). With three exceptions, Km for controls (no. = 12) ranged from 31.8 to 42.8 microM. Km of the three exceptional controls were 21.5, 23.7, and 22.4 microM (the latter two are identical twins). pH optima of enzyme from these three strains were no different from that of known HZ. The correlation between two kinetic parameters of an enzyme and the three CF genotypes suggests an association between the CF gene and mitochondrial NADH dehydrogenase.

Citing Articles

Heightened mitochondrial respiration in CF cells is normalised by triple CFTR modulator therapy through mechanisms involving calcium.

Jarosz-Griffiths H, Caley L, Lara-Reyna S, Savic S, Clifton I, McDermott M Heliyon. 2024; 10(20):e39244.

PMID: 39498005 PMC: 11532250. DOI: 10.1016/j.heliyon.2024.e39244.


The Distribution and Role of the CFTR Protein in the Intracellular Compartments.

Lukasiak A, Zajac M Membranes (Basel). 2021; 11(11).

PMID: 34832033 PMC: 8618639. DOI: 10.3390/membranes11110804.


Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model.

Zarei K, Stroik M, Gansemer N, Thurman A, Ostedgaard L, Ernst S Lab Invest. 2020; 100(11):1388-1399.

PMID: 32719544 PMC: 7578062. DOI: 10.1038/s41374-020-0474-8.


Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.

Causer A, Shute J, Cummings M, Shepherd A, Gruet M, Costello J Redox Biol. 2020; 32:101436.

PMID: 32044291 PMC: 7264436. DOI: 10.1016/j.redox.2020.101436.


Alterations of skeletal muscle bioenergetics in a mouse with F508del mutation leading to a cystic fibrosis-like condition.

Lai N, Kummitha C, Drumm M, Hoppel C Am J Physiol Endocrinol Metab. 2019; 317(2):E327-E336.

PMID: 31211618 PMC: 6732463. DOI: 10.1152/ajpendo.00064.2019.


References
1.
di SantAgnese P, DAVIS P . Research in cystic fibrosis (second of three parts). N Engl J Med. 1976; 295(10):534-41. DOI: 10.1056/NEJM197609022951005. View

2.
Shapiro B, Feigal R, Laible N, Biros M, Warwick W . Doubling time alpha-aminoisobutyrate transport and calcium exchange in cultured fibroblasts from cystic fibrosis and control subjects. Clin Chim Acta. 1978; 82(1-2):125-31. DOI: 10.1016/0009-8981(78)90035-9. View

3.
HATEFI Y . Preparation and properties of NADH: ubiquinone oxidoreductase (complexI), EC 1.6.5.3. Methods Enzymol. 1978; 53:11-4. DOI: 10.1016/s0076-6879(78)53006-1. View

4.
Feigal R, Shapiro B . Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis. Nature. 1979; 278(5701):276-7. DOI: 10.1038/278276a0. View

5.
Shapiro B, Lam L, Fast L . Premature senescence in cultured skin fibroblasts from subjects with cystic fibrosis. Science. 1979; 203(4386):1251-3. DOI: 10.1126/science.424752. View